(Press-News.org) CLEVELAND (Feb. 9)--A study led by Case Western Reserve University researchers found that patients with dementia were at a significantly increased risk for COVID-19--and the risk was higher still for African Americans with dementia.
Reviewing electronic health records of 61.9 million adults in the United States, researchers found the risk of contracting COVID-19 was twice as high for patients with dementia than for those without it--while among those with dementia, African Americans had close to three times the risk of being infected with COVID-19 as Caucasians did.
In addition, patients with dementia who contracted COVID-19 had significantly worse outcomes in terms of hospitalizations and deaths than those who had COVID-19 but not dementia.
The study was published Feb. 9 by the peer-reviewed Alzheimer's & Dementia: The Journal of the Alzheimer's Association and highlights the need to protect people with dementia--particularly African Americans--as part of the strategy to control the pandemic.
An estimated 5.8 million Americans age 65 and older and 50 million people worldwide are living with Alzheimer's and other dementias, according to the Alzheimer's Association.
"Our results emphasize how important it is to protect those with dementia from acquiring SARS-CoV2, for they are at higher risk for severe disease than those without dementia," said study co-author Pamela Davis, dean emerita of the Case Western Reserve School of Medicine. "These patients may constitute another vulnerable category. However, more work is required to understand the mechanism by which this occurs."
The study's authors also include two other members of the School of Medicine: Rong Xu, principal investigator on the research and a professor of biomedical informatics and director of the Center for Artificial Intelligence in Drug Discovery, and QuanQiu Wang, a specialist in artificial intelligence. Co-author Mark Gurney is founder and CEO of Tetra Therapeutics, a drug development company focused on brain disorders and injuries based in Grand Rapids, Michigan, and a wholly owned subsidiary of Shionogi & Co., Ltd.
They hypothesized the risk of COVID-19 would be greater for patients with dementia for several reasons, including: People with dementia may be more susceptible to contracting COVID-19 because of blood-brain barrier damage that can allow certain viruses and bacteria to reach the brain more easily.
In addition, dementia may interfere with a person's ability to wear a mask, physically distance from others or frequently clean their hands. Moreover, conditions such as cardiovascular diseases, diabetes, obesity and hypertension are risk factors for both dementia and COVID-19 and are associated with worse outcomes.
"On behalf of the millions of people living with Alzheimer's and other dementia that we represent, these preliminary findings suggest a frightening reality of the vulnerabilities associated with dementia," said Maria Carrillo, PhD, Alzheimer's Association chief science officer. "It is critical we develop and implement strategies that strike a balance between keeping people, especially long-term care residents, safe from COVID-19 but also protecting them from health-related harms associated with social isolation."
Researchers examined electronic health records (stripped of identifying information) from 360 hospitals and 317,000 providers nationally, representing 20% of the U.S. population. Of the 61.9 million adults in the study population, more than one million had dementia, 15,770 had COVID-19 and 810 had both.
"The availability of such a large de-identified database of patient electronic health records analyzed by modern informatics techniques gave our study great power to detect vulnerabilities in patient disease groupings," Xu said.
The researchers also adjusted the data to account for factors including age, gender, race, other health conditions and whether individuals lived in a nursing home. They used an adjusted odds ratio to determine risk.
Their findings:
While overall the odds of contracting COVID-19 were twice as high for patients with dementia compared to those without dementia, the risk varied by condition. Patients with vascular dementia had the highest risk--with odds more than three times higher-- followed by patients with presenile dementia, senile dementia, Alzheimer's disease and post-traumatic dementia.
The odds of African Americans with dementia contracting COVID-19 were almost three times higher than for Caucasians with dementia. Generally, gender had no additional effects on the risk of COVID-19 in patients with dementia, while age had no additional effects in patients with dementia in general and Alzheimer's specifically.
The overall hospitalization risk during the six months for adults with COVID-19 was 25.17%. But among patients with COVID-19 and dementia, 59.26% were hospitalized, and the percentage was even higher--73.08%-- among African American patients, compared to 53.85% of Caucasians with both conditions.
The overall mortality risk for patients with COVID-19 was 5.64%. But among those who also had dementia, 20.99% died, with the percentage higher for African Americans (23.08%) than for Caucasians (19.23%).
INFORMATION:
This work was supported by the National Institutes of Health's National Institute on Aging (grant numbers AG057557, AG061388,AG062272) and the National Center for Advancing Translational Sciences (grant numberUL1TR002548-01).
Case Western Reserve University is one of the country's leading private research institutions. Located in Cleveland, we offer a unique combination of forward-thinking educational opportunities in an inspiring cultural setting. Our leading-edge faculty engage in teaching and research in a collaborative, hands-on environment. Our nationally recognized programs include arts and sciences, dental medicine, engineering, law, management, medicine, nursing and social work. About 5,100 undergraduate and 6,700 graduate students comprise our student body. Visit case.edu to see how Case Western Reserve thinks beyond the possible.
KEY STUDY FINDINGS INCLUDE:
2.9% of U.S. adults report a current peanut allergy.
About one in six adults with a peanut allergy developed it after age 18.
Approximately one in five adults with peanut allergy report visiting the emergency department for food allergy treatment each year.
Patients who developed their peanut allergy during adulthood are less likely to report having an epinephrine auto-injector prescription than those who developed their peanut allergy during childhood, despite similar frequencies of severe reactions among both groups.
CHICAGO --- Peanut allergy affects at least 4.5 million adults in the U.S., many of whom report developing their ...
Researchers at Baylor College of Medicine and other institutions have identified a novel strategy that can eliminate bacteria in a specific location before they cause an infection. The strategy uses a phage, a virus that infects and destroys bacteria, that can specifically locate in the same place the bacteria live in the gastrointestinal tract. The proximity between phage and bacteria facilitates the phage's attack and subsequent elimination of the bacteria.
This strategy has the potential of becoming a game changer in the fight against antibiotic-resistant bacteria ...
DALLAS, Feb. 9, 2021 -- Participants in a two-year, lifestyle intervention/weight-loss program provided through health coaches at their primary care center were able to lower their blood sugar and improve their cholesterol levels, according to new research published today in the American Heart Association's flagship journal Circulation Journal. Researchers with the PROmoting Successful Weight Loss in Primary CarE in Louisiana (PROPEL) Trial reported previously that participants also reduced body weight by an average of 5% and note that patients who lost more weight experienced greater improvements in their heart disease risk factors.
"Our results demonstrate lifestyle intervention and weight-loss programs can be successful for people in underserved, low-income ...
DALLAS, Feb. 9, 2021 -- Dietary information from three large, well-known heart disease studies suggests drinking one or more cups of caffeinated coffee may reduce heart failure risk, according to research published today in Circulation: Heart Failure, an American Heart Association journal.
Coronary artery disease, heart failure and stroke are among the top causes of death from heart disease in the U.S. "While smoking, age and high blood pressure are among the most well-known heart disease risk factors, unidentified risk factors for heart disease remain," according to David P. Kao, M.D., senior author of the study, assistant professor of cardiology and medical director at the Colorado Center for Personalized Medicine at the University of Colorado School of Medicine ...
In 2017, a widely cited study used statistical tools to model how likely the world is to meet the Paris Agreement global temperature targets. The analysis found that on current trends, the planet had only a 5% chance of staying below 2 degrees Celsius warming this century -- the international climate treaty's supposed goal.
Now, the same authors have used their tools to ask: What emissions cuts would actually be required to meet the goal of 2 C warming, considered a threshold for climate stability and climate-related risks such as excessive heat, drought, extreme weather and sea level rise?
The University of Washington study finds that emissions reductions about 80% more ambitious than those in the Paris Agreement, or an average of 1.8% drop in emissions per year rather than 1% ...
New research led by Monterey Bay Aquarium reveals that even the revered white shark cannot escape the impacts of a changing ocean. The study, published in Scientific Reports, finds that unprecedented sightings of juvenile white sharks at the northern end of Monterey Bay signal a significant shift in the young white sharks' range.
Researchers conclude the northward range shift demonstrates the young sharks are being subjected to a loss of suitable thermal habitat, meaning water temperatures within their preferred temperature range are becoming harder to find.
"Nature has many ways to tell us the status quo is being disrupted, but it's up to us to listen," said Monterey Bay Aquarium Chief Scientist Dr. Kyle Van Houtan. "These sharks - by venturing into territory where they have not historically ...
Our consumer products, such as food, cosmetics and clothes, might be filled with nanomaterials - unbeknownst to us. The use of nanomaterials remains unregulated and they do not show up in lists of ingredients. This is a cause of concern since nanomaterials can be more dangerous than COVID-19 in the long term if no safety action is taken: they are tricky to measure, they enter our food chain and, most alarmingly, they can penetrate cells and accumulate in our organs.
Nanotechnology is appearing everywhere, to change our daily lives. Thanks to applications of nanotechnology, we can treat many diseases so efficiently that they'll soon be a thing of the past. We also have materials that are 100 times stronger than steel, batteries that last 10 times longer than ...
The term plankton describes usually very small organisms that drift with the currents in the seas and oceans. Despite their small size, they play an important role for our planet due to their immense quantity. Photosynthesizing plankton, known as phytoplankton, for example, produce half of the oxygen in the atmosphere while binding huge amounts of carbon dioxide (CO2). Since the Southern Ocean around Antarctica is very rich in nutrients, phytoplankton can thrive there. It is therefore a key region for controlling atmospheric CO2 concentrations.
As other nutrients are abundant, scientists have ...
Exposure to radiation can wreak indiscriminate havoc on cells, tissues, and organs. Curiously, however, some tissues are more vulnerable to radiation damage than others.
Scientists have known these differences involve the protein p53, a well-studied tumor-suppressor protein that initiates a cell's auto-destruct programs. Yet, levels of this sentinel protein are often similar in tissues with vastly different sensitivities to radiation, posing the question: How is p53 involved?
A new study by researchers in the Blavatnik Institute at Harvard Medical School, Massachusetts General Hospital, and the Novartis Institutes for BioMedical Research now sheds light on this mystery.
Reporting in Nature Communications on Feb. 9, they describe how cellular survival after radiation exposure depends ...
What is the best way to monitor a brain tumor? This question is at the heart of a new Position Statement published in open-access journal Frontiers in Oncology. The article is the work of a large collaboration of UK experts and stakeholders who met to discuss the value of routinely imaging brain tumor patients to assess their tumor treatment response, which is known as "interval imaging". Their verdict: there is very limited evidence to support the practice at present. However, the article also discusses how future research could determine and maximize the value of interval ...
